Discrimination between COPD patients with and without alpha 1‐antitrypsin deficiency using an electronic nose

Abstract

An electronic nose can detect differences in smell prints of COPD patients with and without AAT deficiency. Augmentation therapy changes the volatile organic compound pattern. The electronic nose may be helpful in the diagnosis of AAT deficiency.